COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.

Notice

Our blog search feature is temporarily unavailable while we work to resolve an issue. We apologize for the inconvenience and appreciate your patience. We’ll restore it as soon as possible.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202405_BB_Quinacrine_900w.jpg

As one of the most studied synthetic drugs in modern history, quinacrine HCI was first used as an antimalarial and later to treat rheumatic skin diseases, including lupus. With May designated as Lupus Awareness month, learn more about quinacrine HCI and the twists and turns of its storied past.